Re-estimating the prevalence of psychiatric disorders in a nationally representative sample of persons receiving care for HIV: results from the HIV cost and services utilization study-Reference-Cited by-同舟云学术

Re-estimating the prevalence of psychiatric disorders in a nationally representative sample of persons receiving care for HIV: results from the HIV cost and services utilization study

Published:2002-06 Issue:2 Volume:11 Page:75-82
ISSN:1049-8931
Container-title:International Journal of Methods in Psychiatric Research
language:en
Short-container-title:Int. J. Method. Psychiat. Res.

Author:

Orlando Maria,Burnam M. Audrey,Beckman Robin,Morton Sally C.,London Andrew S.,Bing Eric G.,Fleishman John A.

Publisher

Wiley

Subject

Psychiatry and Mental health

Reference25 articles.

1. Prevalence of Psychiatric Disorders Among Men Infected With Human Immunodeficiency Virus

2. , , , and members of the HCSUS Consortium. HCSUS Baseline Patient Questionnaire. MR-1090-AHCPR. Santa Monica CA: RAND, 1999.

3. Psychiatric Disorders and Drug Use Among Human Immunodeficiency Virus–Infected Adults in the United States

4. The Care of HIV-Infected Adults in the United States

Cited by 113 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Provocative findings from a transdiagnostic counseling intervention to improve psychiatric comorbidity and HIV care engagement among people with HIV: A Pilot Randomized Clinical Trial;JAIDS Journal of Acquired Immune Deficiency Syndromes;2024-05-09

2. Acute Effects of Monoacylglycerol Lipase Inhibitor ABX1431 on Neuronal Hyperexcitability, Nociception, Locomotion, and the Endocannabinoid System in HIV-1 Tat Male Mice;Cannabis and Cannabinoid Research;2024-02-23

3. Latent Profile Analysis of Cognitive Performance and Depressive Symptoms Among People with HIV;AIDS Patient Care and STDs;2024-02-01

4. Biopsychosocial phenotypes in people with HIV in the CHARTER cohort;Brain Communications;2024

5. Predicting the effectiveness of combination treatment of dolutegravir and fluoxetine for depressive disorders in HIV;HIV-Associated Neurocognitive Disorders;2024